Article info
Review
Epilepsy and pregnancy: identifying risks
- Correspondence to Professor John Paul Leach, School of Medicine, University of Glasgow, Glasgow G12 8QQ, UK; John.Leach{at}glasgow.ac.uk
Citation
Epilepsy and pregnancy: identifying risks
Publication history
- Accepted October 24, 2021
- First published December 9, 2021.
Online issue publication
March 17, 2022
Article Versions
- Previous version (9 December 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Management of epilepsy during pregnancy and lactation
- Epilepsy in pregnancy
- Antiepileptics, pregnancy and the child
- Drug treatment of epilepsy in adults
- Epilepsy in women: a practical guide to management
- Epilepsies in children, young people, and adults: summary of updated NICE guidance
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register
- Newer drugs for focal epilepsy in adults
- Treating women with juvenile myoclonic epilepsy
- Risk of seizures with antidepressants: what is the evidence?